|
|
||||||||
Ann Thorac Surg 1994;58:704-711
© 1994 The Society of Thoracic Surgeons
Department of Thoracic and Cardiovascular Surgery, Section of Pulmonary and Critical Care Medicine, and Department of Radiotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas USA
* Address reprint requests to Dr Walsh. Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Box 109, 1515 Holcombe Blvd, Houston, TX 77030.
The medical criteria for inoperability have been difficult to define in patients with lung cancer. Sixty-six patients with non-small cell lung cancer and radiographically resectable lesions were evaluated prospectively in a clinical trial. The patients were considered by cardiac or pulmonary criteria to be high risk for pulmonary resection. If exercise testing revealed a peak oxygen uptake of 15 mL · kg–1 · min–1 or greater, the patient was offered surgical treatment. Of the 20 procedures performed, nine were lobectomies, two were bilobectomies, and nine were wedge or segmental resections. All patients were extubated within 24 hours and discharged within 22 days after operation (median time to discharge, 8 days). There were no deaths, and complications occurred in 8 (40%) of the 20 patients. Five patients whose peak oxygen uptake was lower than 15 mL · kg–1 · min–1 also underwent surgical intervention; there was one death. Thirty-four patients whose peak oxygen uptake was less than 15 mL · kg–1 · min–1 and 7 who declined operation underwent radiation therapy alone (35 patients) or radiation therapy and chemotherapy (6 patients). There were no treatment-related deaths, and the morbidity rate was 12% ( [equation]). The median duration of survival was 48 ± 4.3 months for the patients treated surgically and 17 ± 2.7 months for those treated medically (p = 0.0014). We conclude that a subgroup of patients who would be considered to have inoperable disease by traditional medical criteria can be selected for operation on the basis of oxygen consumption exercise testing. There is a striking survival benefit to an aggressive surgical approach in these patients.
This article has been cited by other articles:
![]() |
L. Puente-Maestu, F. Villar, G. Gonzalez-Casurran, N. Moreno, Y. Martinez, C. Simon, R. Penalver, and F. Gonzalez-Aragoneses Early and Long-term Validation of an Algorithm Assessing Fitness for Surgery in Patients With Postoperative FEV1 and Diffusing Capacity of the Lung for Carbon Monoxide < 40% Chest, June 1, 2011; 139(6): 1430 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Bernstein and S. Deshpande Preoperative Evaluation for Thoracic Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 109 - 121. [Abstract] [PDF] |
||||
![]() |
G. L. Colice, S. Shafazand, J. P. Griffin, R. Keenan, and C. T. Bolliger Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 161S - 177S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF] |
||||
![]() |
P. Magdeleinat, A. Seguin, M. Alifano, S. Boubia, and J.-F. Regnard Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment Eur J Cardiothorac Surg, June 1, 2005; 27(6): 1099 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Shaw, A. A. Vaporciyan, X. Wu, T. M. King, M. R. Spitz, J. B. Putnam, and B. F. Dickey Inflammatory Gene Polymorphisms Influence Risk of Postoperative Morbidity After Lung Resection Ann. Thorac. Surg., May 1, 2005; 79(5): 1704 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Beckles, S. G. Spiro, G. L. Colice, and R. M. Rudd The Physiologic Evaluation of Patients With Lung Cancer Being Considered for Resectional Surgery Chest, January 1, 2003; 123(2009): 105S - 114S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chenuel, P. Haouzi, P. Olivier, P.Y. Marie, B. Chalon, and J. Borrelly Effect of exercise on lung-perfusion scanning in patients with bronchogenic carcinoma Eur. Respir. J., September 1, 2002; 20(3): 710 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Handy Jr, J. W. Asaph, L. Skokan, C. E. Reed, S. Koh, G. Brooks, E. C. Douville, A. C. Tsen, G. Y. Ott, and G. A. Silvestri What Happens to Patients Undergoing Lung Cancer Surgery?* : Outcomes and Quality of Life Before and After Surgery Chest, July 1, 2002; 122(1): 21 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, D. Beggs, M. L. Rogers, L. Beggs, S. Asopa, and F. D. Salama Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival Eur J Cardiothorac Surg, September 1, 2001; 20(3): 476 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britai, and Ireland Working Party Guidelines on the selection of patients with lung cancer for surgery Thorax, February 1, 2001; 56(2): 89 - 108. [Full Text] |
||||
![]() |
A. Bernard, L. Ferrand, O. Hagry, L. Benoit, N. Cheynel, and J.-P. Favre Identification of prognostic factors determining risk groups for lung resection Ann. Thorac. Surg., October 1, 2000; 70(4): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
A-M Nugent, I C Steele, A M Carragher, K McManus, J A McGuigan, J R P Gibbons, M S Riley, and D P Nicholls Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer Thorax, April 1, 1999; 54(4): 334 - 338. [Abstract] [Full Text] |
||||
![]() |
J. Wang, J. Olak, and M. K. Ferguson DIFFUSING CAPACITY PREDICTS OPERATIVE MORTALITY BUT NOT LONG-TERM SURVIVAL AFTER RESECTION FOR LUNG CANCER J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thomas, M. Piraux, L. F. Jacques, J. Gregoire, P. Bedard, and J. Deslauriers Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma Eur J Cardiothorac Surg, March 1, 1998; 13(3): 266 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. DeRose Jr, M. Argenziano, N. El Amir, L. A. Gorenstein, K. M. Steinglass, B. Thomashow, and M. E. Ginsburg Lung Reduction Operation and Resection of Pulmonary Nodules in Patients With Severe Emphysema Ann. Thorac. Surg., February 1, 1998; 65(2): 314 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Melendez and M. E. Fischer Predicting Postoperative Outcome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1997; 1(3): 199 - 207. [Abstract] [PDF] |
||||
![]() |
M. Ninan, K. E. Sommers, R. J. Landreneau, R. J. Weyant, J. Tobias, J. D. Luketich, P. F. Ferson, and R. J. Keenan Standardized Exercise Oximetry Predicts Postpneumonectomy Outcome Ann. Thorac. Surg., August 1, 1997; 64(2): 328 - 332. [Abstract] [Full Text] |
||||
![]() |
L. Wetstein and J. R. Mault Physiologic Evaluation of the Lung Resection Candidate Ann. Thorac. Surg., September 1, 1996; 62(3): 923 - 923. [Full Text] |
||||
![]() |
V. Rao, T. R. J. Todd, A. Kuus, K. J. Buth, and F. G. Pearson Exercise oximetry versus spirometry in the assessment of risk prior to lung resection Ann. Thorac. Surg., September 1, 1995; 60(3): 603 - 609. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |